Ascent Bridge Signs Cooperation Framework with Scinosen Gene Industry
Ascent Bridge and Scinosen Forge Strategic Partnership
Ascent Bridge Ltd (SGX: AWG), a Singapore-based company, has entered into a cooperation framework agreement with Scinosen (Shenzhen) Gene Industry Development. The agreement aims to expand Scinosen's Gendicine business.
Details of the Agreement
The partnership combines Ascent Bridge's financial and strategic resources with Scinosen's expertise in the gene industry to accelerate the growth of the Gendicine business. This collaboration is expected to create new opportunities for both entities.
Market Impact
The news may influence Ascent Bridge's stock performance. Investors are assessing how this strategic move contributes to the company's growth potential.
The news, analyses, and comments on this platform do not constitute investment advice. When making investment decisions, you should conduct your own research and consult with a qualified financial advisor if necessary. FiNews cannot be held responsible for any losses that may arise from the use of this information.